MERIT MEDICAL SYSTEMS INC 10-Q

ITEM 5. OTHER INFORMATION None of our directors or officers informed us of the adop tion or termi nation of a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as those terms are defined in Item 408 of Regulation S-K, during the three-month period ended June 30, 2025. 44 Table of Contents ITEM 6. EXHIBITS Exhibit No. Description 2.1 ​ Agreement and Plan of Merger by and among Merit Medical Systems, Inc., Biolife Transaction Sub, LLC, Biolife, L.L.C., and Shareholder Representative Services LLC, dated as of May 16, 2025. 3.1 ​ Second Amended and Restated Articles of Incorporation.* 3.2 ​ Fourth Amended and Restated Bylaws.* 10.1 ​ Form of Restricted Stock Unit Award Agreement, dated May 15, 2025, by and between Merit Medical Systems, Inc. and each of the following individuals: Lonny J. Carpenter, Stephen C. Evans, David K. Floyd, Thomas J. Gunderson, Laura S. Kaiser, Michael R. McDonnell, F. Ann Millner, Silvia M. Perez and Lynne N. Ward. † 19.1 ​ Corporate Policy on Insider Trading (revised May 15, 2025). 31.1 ​ Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 . 31.2 ​ Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 . 32.1 ​ Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 . 32.2 ​ Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 . 101 ​ The following financial information from the quarterly report on Form 10-Q for the quarter ended June 30, 2025, formatted in Inline Extensible Business Reporting Language (iXBRL): (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Income, (iii) Consolidated Statements of Comprehensive Income (iv) Consolidated Statements of Stockholders’ Equity, (v) Consolidated Statements of Cash Flows, and (vi) related Condensed Notes to the Unaudited Consolidated Financial Statements, tagged in detail. 104 Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document). * These exhibits are incorporated herein by reference. † Indicates management contract or compensatory plan or arrangement. ​ ​ 45 Table of Contents ​ SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. ​ ​ ​ ​ ​ MERIT MEDICAL SYSTEMS, INC. ​ ​ ​ Date: July 30, 2025 By: /s/ FRED P. LAMPROPOULOS ​ ​ Fred P. Lampropoulos ​ ​ Chief Executive Officer and President ​ ​ ​ ​ Date: July 30, 2025 By: /s/ RAUL PARRA ​ ​ Raul Parra ​ ​ Chief Financial Officer and Treasurer ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 46